In Reply
Obstet Gynecol
.
2020 Sep;136(3):635-636.
doi: 10.1097/AOG.0000000000004068.
Authors
David Chelmow
1
,
Mark D Pearlman
2
,
Amy Young
3
,
Laura Bozzuto
4
,
Sandra Dayaratna
5
,
Myrlene Jeudy
6
,
Mallory Kremer
7
,
Dana Marie Scott
8
,
Julia Sage O'Hara
9
Affiliations
1
Department of Obstetrics and Gynecology, Virginia Commonwealth University School of Medicine, Richmond, Virginia.
2
Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor, Michigan.
3
Department of Women's Health, the University of Texas at Austin Dell Medical School, Austin, Texas.
4
Department of Obstetrics and Gynecology, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
5
Department of Obstetrics and Gynecology, Thomas Jefferson University Hospital, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
6
Southeast Kaiser Permanente Medical Group, Atlanta, Georgia.
7
Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington.
8
Department of Obstetrics and Gynecology, University of Connecticut Medical School, Farmington, Connecticut.
9
American College of Obstetricians and Gynecologists, Washington, DC.
PMID:
32826586
DOI:
10.1097/AOG.0000000000004068
No abstract available
Publication types
Comment
MeSH terms
Breast Neoplasms*
Humans